GL Pharm Tech Corp. (KOSDAQ:204840)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,065.00
+3.00 (0.28%)
At close: Apr 28, 2026
-20.64%
Market Cap 82.59B
Revenue (ttm) 35.27B
Net Income (ttm) 12.49M
Shares Out 77.55M
EPS (ttm) n/a
PE Ratio 6,613.01
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 162,084
Average Volume 178,725
Open 1,062.00
Previous Close 1,062.00
Day's Range 1,005.00 - 1,085.00
52-Week Range 1,000.00 - 1,470.00
Beta 0.57
RSI 50.80
Earnings Date May 12, 2026

About GL Pharm Tech

GL Pharm Tech Corp. provides generic drugs and incrementally modified drug (IMD) formulation technology to pharmaceutical companies in South Korea. The company offers IMD for gastritis, antidepressant, anorectic, and antibiotic indications. It also provides generic drugs for cardiovascular, urology, pain, anti-infection, gastric disease, diabetes, central nervous system disease, respiratory disease, transplantation, and other areas. In addition, the company engages in developing new molecule entity pipeline products for dry eye disease. Further... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 33
Stock Exchange KOSDAQ
Ticker Symbol 204840
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.